Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | UTHR | Common Stock | Options Exercise | $0 | +1.08K | +64.29% | $0.00 | 2.76K | Jul 8, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | UTHR | Restricted Stock Unit | Options Exercise | $0 | -1.08K | -100% | $0.00* | 0 | Jul 8, 2022 | Common Stock | 1.08K | $0.00 | Direct | F2, F3 |
transaction | UTHR | Restricted Stock Unit | Award | $0 | +880 | $0.00 | 880 | Jul 7, 2022 | Common Stock | 880 | $0.00 | Direct | F2, F3, F4 | |
transaction | UTHR | Stock Options | Award | $0 | +2.49K | $0.00 | 2.49K | Jul 7, 2022 | Common Stock | 2.49K | $240.20 | Direct | F3, F4 |
Id | Content |
---|---|
F1 | Shares received upon vesting of restricted stock units on July 8, 2022. Restricted stock units converted on a one-for-one basis into shares of common stock. |
F2 | Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. |
F3 | Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. |
F4 | Annual non-employee director award. |